LUCID study

Liberal glUcose Control in critically Ill patients with pre-existing type 2 Diabetes (LUCID): a phase II multicentre randomised controlled trial to evaluate the prevalence and effect of hypoglycaemia. Critically ill patients admitted to ICU with T2DM, demographics, ICU admission details, treatments at enrolment, blood glucose concentrations during admission, insulin administration during admission, ICU, Hospital, day 28 and day 90 outcome data.